Skip to main content

Good Therapeutics being acquired by Roche for $250M

The Seattle-based biotech will form a new company called Bonum Therapeutics after the acquisition.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.